221 related articles for article (PubMed ID: 35301869)
21. Long-Term Prognostic Value of High-Sensitivity Troponin T Added to N-Terminal Pro Brain Natriuretic Peptide Plasma Levels Before Valve Replacement for Severe Aortic Stenosis.
Barbieri F; Senoner T; Adukauskaite A; Dobner S; Holfeld J; Semsroth S; Lambert T; Zweiker D; Theurl T; Rainer PP; Schmidt A; Feuchtner GM; Steinwender C; Hoppe UC; Hintringer F; Bauer A; Müller S; Grimm M; Pfeifer BE; Dichtl W
Am J Cardiol; 2019 Dec; 124(12):1932-1939. PubMed ID: 31699359
[TBL] [Abstract][Full Text] [Related]
22. Regression of Left Ventricular Mass After Transcatheter Aortic Valve Replacement: The PARTNER Trials and Registries.
Chau KH; Douglas PS; Pibarot P; Hahn RT; Khalique OK; Jaber WA; Cremer P; Weissman NJ; Asch FM; Zhang Y; Gertz ZM; Elmariah S; Clavel MA; Thourani VH; Daubert M; Alu MC; Leon MB; Lindman BR
J Am Coll Cardiol; 2020 May; 75(19):2446-2458. PubMed ID: 32408979
[TBL] [Abstract][Full Text] [Related]
23. Prognostic utility of N-terminal pro B-type natriuretic peptide ratio in mixed aortic valve disease.
Bernard J; Jean G; Bienjonetti-Boudreau D; Jacques F; Tastet L; Salaun E; Clavel MA
Open Heart; 2023 Jul; 10(2):. PubMed ID: 37474135
[TBL] [Abstract][Full Text] [Related]
24. Is elevation of N-terminal pro-B-type natriuretic peptide at discharge associated with 2-year composite endpoint of all-cause mortality and heart failure hospitalisation after transcatheter aortic valve implantation? Insights from a multicentre prospective OCEAN-TAVI registry in Japan.
Mizutani K; Hara M; Nakao M; Okai T; Kajio K; Murakami T; Shibata T; Yoshiyama M; Naganuma T; Yamanaka F; Higashimori A; Tada N; Takagi K; Araki M; Ueno H; Tabata M; Shirai S; Watanabe Y; Yamamoto M; Hayashida K
BMJ Open; 2018 Aug; 8(8):e021468. PubMed ID: 30121598
[TBL] [Abstract][Full Text] [Related]
25. NT-proBNP changes, oxidative stress, and energy status of hypertrophic myocardium following ischemia/reperfusion injury.
Scolletta S; Carlucci F; Biagioli B; Marchetti L; Maccherini M; Carlucci G; Rosi F; Salvi M; Tabucchi A
Biomed Pharmacother; 2007; 61(2-3):160-6. PubMed ID: 17350221
[TBL] [Abstract][Full Text] [Related]
26. Early regression of severe left ventricular hypertrophy after transcatheter aortic valve replacement is associated with decreased hospitalizations.
Lindman BR; Stewart WJ; Pibarot P; Hahn RT; Otto CM; Xu K; Devereux RB; Weissman NJ; Enriquez-Sarano M; Szeto WY; Makkar R; Miller DC; Lerakis S; Kapadia S; Bowers B; Greason KL; McAndrew TC; Lei Y; Leon MB; Douglas PS
JACC Cardiovasc Interv; 2014 Jun; 7(6):662-73. PubMed ID: 24947722
[TBL] [Abstract][Full Text] [Related]
27. Elevation of B-Type Natriuretic Peptide at Discharge is Associated With 2-Year Mortality After Transcatheter Aortic Valve Replacement in Patients With Severe Aortic Stenosis: Insights From a Multicenter Prospective OCEAN-TAVI (Optimized Transcatheter Valvular Intervention-Transcatheter Aortic Valve Implantation) Registry.
Mizutani K; Hara M; Iwata S; Murakami T; Shibata T; Yoshiyama M; Naganuma T; Yamanaka F; Higashimori A; Tada N; Takagi K; Araki M; Ueno H; Tabata M; Shirai S; Watanabe Y; Yamamoto M; Hayashida K
J Am Heart Assoc; 2017 Jul; 6(7):. PubMed ID: 28710182
[TBL] [Abstract][Full Text] [Related]
28. Impact of preprocedural left ventricle hypertrophy and geometrical patterns on mortality following TAVR.
Rozenbaum Z; Finkelstein A; Zhitomirsky S; Topilsky Y; Halkin A; Banai S; Bazan S; Barbash I; Segev A; Guetta V; Danenberg H; Planner D; Orvin K; Assa HV; Assali A; Kornowski R; Steinvil A
Am Heart J; 2020 Feb; 220():184-191. PubMed ID: 31862472
[TBL] [Abstract][Full Text] [Related]
29. The evolution and prognostic value of N-terminal brain natriuretic peptide in predicting 1-year mortality in patients following transcatheter aortic valve implantation.
Elhmidi Y; Bleiziffer S; Piazza N; Ruge H; Krane M; Deutsch MA; Hettich I; Voss B; Mazzitelli D; Lange R
J Invasive Cardiol; 2013 Jan; 25(1):38-44. PubMed ID: 23293174
[TBL] [Abstract][Full Text] [Related]
30. Sex and regional differences in myocardial plasticity in aortic stenosis are revealed by 3D model machine learning.
Bhuva AN; Treibel TA; De Marvao A; Biffi C; Dawes TJW; Doumou G; Bai W; Patel K; Boubertakh R; Rueckert D; O'Regan DP; Hughes AD; Moon JC; Manisty CH
Eur Heart J Cardiovasc Imaging; 2020 Apr; 21(4):417-427. PubMed ID: 31280289
[TBL] [Abstract][Full Text] [Related]
31. Post-procedural N-terminal pro-brain natriuretic peptide predicts one-year mortality after transcatheter aortic valve implantation.
Vale NC; Campante Teles R; Madeira S; Brito J; Sousa Almeida M; Nolasco T; Abecasis J; Rodrigues G; Carmo J; Furstenau M; Ribeiras R; Neves JP; Mendes M
Rev Port Cardiol (Engl Ed); 2018 Jan; 37(1):67-73. PubMed ID: 29317115
[TBL] [Abstract][Full Text] [Related]
32. Elevated N-terminal pro C-type natriuretic peptide is associated with mortality in patients undergoing transcatheter aortic valve replacement.
Hu P; Chen H; Wang LH; Jiang JB; Li JM; Tang MY; Guo YC; Zhu QF; Pu ZX; Lin XP; Ng S; Liu XB; Wang JA
BMC Cardiovasc Disord; 2022 Apr; 22(1):164. PubMed ID: 35413789
[TBL] [Abstract][Full Text] [Related]
33. Impact of Left Ventricular Diastolic Dysfunction and Biomarkers on Pulmonary Hypertension in Patients with Severe Aortic Stenosis.
Gumauskienė B; Krivickienė A; Jonkaitienė R; Vaškelytė JJ; Siudikas A; Ereminienė E
Medicina (Kaunas); 2018 Sep; 54(4):. PubMed ID: 30344294
[No Abstract] [Full Text] [Related]
34. Prognostic Value of N-Terminal Pro-B-Type Natriuretic Peptide in Elderly Patients With Valvular Heart Disease.
Zhang B; Xu H; Zhang H; Liu Q; Ye Y; Hao J; Zhao Q; Qi X; Liu S; Zhang E; Xu Y; Gao R; Pibarot P; Clavel MA; Wu Y;
J Am Coll Cardiol; 2020 Apr; 75(14):1659-1672. PubMed ID: 32273031
[TBL] [Abstract][Full Text] [Related]
35. Evaluation of N-terminal prohormone of brain natriuretic peptide and cardiac troponin-I levels in cats with systolic anterior motion of the mitral valve in the absence of left ventricular hypertrophy.
Ferasin L; Kilkenny E; Ferasin H
J Vet Cardiol; 2020 Aug; 30():23-31. PubMed ID: 32645686
[TBL] [Abstract][Full Text] [Related]
36. Baseline NT-proBNP Accurately Predicts Symptom Response to Transcatheter Aortic Valve Implantation.
Allen CJ; Joseph J; Patterson T; Hammond-Haley M; McConkey HZR; Prendergast BD; Marber M; Redwood SR
J Am Heart Assoc; 2020 Dec; 9(23):e017574. PubMed ID: 33241754
[TBL] [Abstract][Full Text] [Related]
37. Combined use of high-sensitivity cardiac troponin T and N-terminal pro-B type natriuretic peptide improves measurements of performance over established mortality risk factors in chronic heart failure.
de Antonio M; Lupon J; Galan A; Vila J; Urrutia A; Bayes-Genis A
Am Heart J; 2012 May; 163(5):821-8. PubMed ID: 22607860
[TBL] [Abstract][Full Text] [Related]
38. Early changes in N-terminal pro-B-type natriuretic peptide levels after transcatheter aortic valve replacement and its impact on long-term mortality.
Liebetrau C; Gaede L; Kim WK; Arsalan M; Blumenstein JM; Fischer-Rasokat U; Wolter JS; Kriechbaum S; Huber MT; van Linden A; Berkowitsch A; Dörr O; Nef H; Hamm CW; Walther T; Möllmann H
Int J Cardiol; 2018 Aug; 265():40-46. PubMed ID: 29885699
[TBL] [Abstract][Full Text] [Related]
39. Evaluation of NT-proBNP concentrations during exercise in asymptomatic patients with severe high-gradient aortic stenosis.
Dobrowolski P; Lech A; Klisiewicz A; Hoffman P
Pol Arch Med Wewn; 2016 Aug; 126(9):635-641. PubMed ID: 27515778
[TBL] [Abstract][Full Text] [Related]
40. Left ventricular hypertrophy as a predictor of cardiovascular outcomes after transcatheter aortic valve replacement.
Ito N; Zen K; Takahara M; Tani R; Nakamura S; Fujimoto T; Takamatsu K; Yashige M; Kadoya Y; Yamano M; Yamano T; Nakamura T; Yaku H; Matoba S
ESC Heart Fail; 2023 Apr; 10(2):1336-1346. PubMed ID: 36725669
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
